Search Results

1 - 10 of 15 items :

  • "diabetes mellitus" x
  • Pharmacy, other x
Clear All
A new diagnostic perspective – hyperglycemia in pregnancy – as of the year, 2014

References 1. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2014 Jan; 37 Suppl 1: 81-90. 2. Barbour L.A. et al.: Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care, 30, 112-19, 2007. 3. Ben-Haroush A., Yogev Y., Hod M.: Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med, 21[2], 103-13, 2004. 4. Briana D.D., Malamitsi-Puchner A.: Reviews

Open access
Flozins, inhibitors of type 2 renal sodium-glucose co-transporter – not only antihyperglycemic drugs

References 1. Bhatia K. et al.: Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data. World J. Diabetes, 5, 399, 2014. 2. Chao E., Henry R.: SGLT2 inhibition - a novel strategy for diabetes treatment. Nature Rev. Drug Discov., 9, 551, 2010. 3. Diamant M., Morsink L.: SGLT2 inhibitors for diabetes: turning symptoms into therapy. Lancet, 382, 917, 2013. 4. Endocrine Today.

Open access
The blood resistin level in patients with DM2, depending on the duration of the disease

; 409: 307-12. 17. Tokuyama Y. et al.: Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism, 2007; 56 (5): 693-698. 18. Vozarova De Courten B. et al.: High serum resistin is associated with an increase in adiposity but not worsening of insulin resistance in Pima Indian. Diabetes, 2004; 53 (9): 1279-1284.

Open access
Hypolipidemic, hepatoprotective, nephroprotective and anti-lipid peroxidation properties of a methanol extract of Paullinia pinnata root-bark, in alloxan-induced hyperglycemic rats

Reference 1. Ajiboye BO, Oloyede HOB, Salawu MO. Antihyperglycemic and antidyslipidemic activity of Musa paradisiaca – based diet in alloxan-induced diabetic rats. Food Sci Nutr. 2018;6:137-45. 2. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus – present and future perspectives. Nat Rev Endocrinol. 2012;8:228-36. 3. Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes

Open access
Omentin - a new adipokine with many roles to play

tissue. Biochim. Biophys. Acta, 1732, 1-3, 2005. 27. Schaffler A., Zeitoun M., Wobser H. et al.: Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in humangene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel disease. Cardiovasc. Diabetol., 6, 3, 2007. 28. Senolt L., Polanska M., Filkova M. et al.: Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann. Rheum. Dis., 69, doi:10.1136/ ard

Open access
The Antidepressants and the Metabolic Syndrome

-faceted effects. Oncogene. Nature Publishing Group; 2012;32:1475–87. 14. Kun IZ, Kun I, Kun IZJ. Metabolikus szindróma, diabetes mellitus és a rosszindulatú daganatok. Orvostudományi Értesítő. 2015;88:7–18. 15. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J. Clin. Psychiatry. 2010;71:1259–72. 16. Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One. 2014;9:e94112. 17. Neal MJ (ford. Laszlovszky István). Rövid farmakológia. B

Open access
Application of mesenchymal stem cells in paediatrics

implantation of Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J 60(3):347-57, 2013. 22. Introna M., et al.: Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Biol Blood Marrow Transplant. 20(3):375-81, 2014. doi: 10.1016/j.bbmt.2013.11.033. 23. Jin J.L., et al.: Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia. Curr Neurovasc Res 10

Open access
Central sleep apnea – a case report

(1):61-66, 2008. 9. Hormann C. et al.: Biphasic positive airway pressure (BIPAP)- a new mode of ventilatory support. Eur. J. Anaesthesiol., 11(1), 37-42, 1994. 10. Martins R.C., Andersen M.L., Tufik S.: The reciprocal interaction between sleep and type 2 diabetes mellitus: facts and perspectives.Braz. J. Med. Biol. Res., 41 (3): 180-187, 2008.

Open access
Risks associated with betel quid chewing

. 18. Secretan B. et al.: WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol., 10, 1033, 2009. 19. Tung T.H. et al.: A population-based study of the association between areca nut chewing and type 2 diabetes mellitus in men (Keelung Community-based Integrated Screening programme No. 2) Diabetologia, 47, 1776, 2004. 20. Tseng C.H.: Betel nut chewing and incidence of newly diagnosed type 2 diabetes mellitus in

Open access
Serum leptin concentration in patients with type 2 diabetes

(3), 377, 2010. 8. Denroche H.C., Huynh F.K., Kieffer T.J.: The role of leptin in glucose homeostasis. J. Diabetes Investig., 3(2), 115, 2012. 9. Esteghamati A. et. al.: Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab. Syndr. Relat. Disord. 7(5), 447, 2009. 10. Esteghamati A. et. al.: Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistant and obesity. Diabetes Res. Clin. Pract

Open access